title: Nanooncology in ovarian cancer treatment.
abstract: In the following review, the authors present various methods of using nanoparticles in the therapy of ovarian cancer. Nanoparticles have been shown to prolong the half-time of various chemotheurapeutics, have a lower toxicity, and increase chemosensitivity. It is their hope that this article will widen the discussion within the scientific community on the use of nanotheurapeutics in oncology.
authors.forename: B
authors.initials: B
authors.lastname: Kasprzak
authors.forename: S
authors.initials: S
authors.lastname: Miskiel
authors.forename: J
authors.initials: J
authors.lastname: Markowska
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016503:Drug Delivery Systems; D005260:Female; D006801:Humans; D008081:Liposomes; D008823:Micelles; D050997:Nanomedicine; D053758:Nanoparticles / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000628:therapy*; D034741:RNA, Small Interfering / Q000627:therapeutic use*; D000067492:RNAi Therapeutics / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents; D008081:Liposomes; D008823:Micelles; D034741:RNA, Small Interfering